Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

The P2Y(14) receptor is a G protein-coupled receptor activated by uridine-5'-diphosphoglucose and other nucleotide sugars that modulates immune function. Covalent conjugation of P2Y(14) receptor agonists to PAMAM (polyamidoamine) dendrimers enhanced pharmacological activity. Uridine-5'-diphosphoglucuronic acid (UDPGA) and its ethylenediamine adduct were suitable functionalized congeners for coupling to several generations (G2.5-6) of dendrimers (both terminal carboxy and amino). Prosthetic groups, including biotin for avidin complexation, a chelating group for metal complexation (and eventual magnetic resonance imaging), and a fluorescent moiety, also were attached with the eventual goals of molecular detection and characterization of the P2Y(14) receptor. The activities of conjugates were assayed in HEK293 cells stably expressing the human P2Y(14) receptor. A G3 PAMAM conjugate containing 20 bound nucleotide moieties (UDPGA) was 100-fold more potent (EC(50) 2.4 nM) than the native agonist uridine-5'-diphosphoglucose. A molecular model of this conjugate docked in the human P2Y(14) receptor showed that the nucleotide-substituted branches could extend far beyond the dimensions of the receptor and be available for multivalent docking to receptor aggregates. Larger dendrimer carriers and greater loading favored higher potency. A similar conjugate of G6 with 147 out of 256 amino groups substituted with UDPGA displayed an EC(50) value of 0.8 nM. Thus, biological activity was either retained or dramatically enhanced in the multivalent dendrimer conjugates in comparison with monomeric P2Y(14) receptor agonists, depending on size, degree of substitution, terminal functionality, and attached prosthetic groups.

[1]  K. Jacobson.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). , 2009, Bioconjugate chemistry.

[2]  T. K. Harden,et al.  Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems , 2009, Journal of Pharmacology and Experimental Therapeutics.

[3]  G. P. Livi,et al.  UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[4]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[5]  K. Jacobson,et al.  Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates , 2008, Journal of nanobiotechnology.

[6]  H. Koerber,et al.  Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2 , 2008, PAIN.

[7]  F. Ciruela,et al.  Detection of higher‐order G protein‐coupled receptor oligomers by a combined BRET–BiFC technique , 2008, FEBS letters.

[8]  Hisataka Kobayashi,et al.  Dendrimer-based contrast agents for molecular imaging. , 2008, Current topics in medicinal chemistry.

[9]  K. Jacobson,et al.  Molecular modeling of a PAMAM-CGS21680 dendrimer bound to an A2A adenosine receptor homodimer. , 2008, Bioorganic & medicinal chemistry letters.

[10]  C. Lindsley,et al.  G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. , 2008, ACS chemical biology.

[11]  K. Jacobson,et al.  Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. , 2008, Bioconjugate chemistry.

[12]  K. Jacobson,et al.  Application of the functionalized congener approach to dendrimer-based signaling agents acting through A2A adenosine receptors , 2008, Purinergic Signalling.

[13]  G. Burnstock.  Purinergic signalling and disorders of the central nervous system , 2008, Nature Reviews Drug Discovery.

[14]  S. Endres,et al.  P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cells. , 2008, Blood.

[15]  K. Jacobson,et al.  Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers. , 2008, Bioconjugate chemistry.

[16]  F. Di Virgilio,et al.  Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells , 2007, Nature Medicine.

[17]  J. Vignon,et al.  Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization. , 2007, European journal of pharmacology.

[18]  Molecular dynamics simulation of the P2Y14 receptor. Ligand docking and identification of a putative binding site of the distal hexose moiety. , 2007, Bioorganic & medicinal chemistry letters.

[19]  D. Tomalia,et al.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. , 2007, Biochemical Society transactions.

[20]  Eric A. Barnard,et al.  International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy , 2006, Pharmacological Reviews.

[21]  J. Dickenson,et al.  Functional expression of the P2Y14 receptor in human neutrophils. , 2006, European journal of pharmacology.

[22]  J. B. Christensen,et al.  Dendrimers in Diagnostics , 2006 .

[23]  R. Larson,et al.  Molecular dynamics studies of the size, shape, and internal structure of 0% and 90% acetylated fifth-generation polyamidoamine dendrimers in water and methanol. , 2006, The journal of physical chemistry. B.

[24]  C. Gachet.  Regulation of platelet functions by P2 receptors. , 2006, Annual review of pharmacology and toxicology.

[25]  H. Ghandehari,et al.  Transepithelial and endothelial transport of poly (amidoamine) dendrimers. , 2005, Advanced drug delivery reviews.

[26]  Antony D'Emanuele,et al.  Dendrimer-drug interactions. , 2005, Advanced drug delivery reviews.

[27]  R. Duncan,et al.  Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.

[28]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[29]  F. Di Virgilio,et al.  The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion. , 2005, American journal of respiratory cell and molecular biology.

[30]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[31]  Hisataka Kobayashi,et al.  Dendrimer-based nanosized MRI contrast agents. , 2004, Current pharmaceutical biotechnology.

[32]  Terry Kim,et al.  Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions. , 2004, Journal of the American Chemical Society.

[33]  Seiko F. Okada,et al.  Nucleotide Release Provides a Mechanism for Airway Surface Liquid Homeostasis* , 2004, Journal of Biological Chemistry.

[34]  William A. Goddard,et al.  Structure of PAMAM dendrimers: Generations 1 through 11 , 2004 .

[35]  David J Singel,et al.  Altering the strength of lectin binding interactions and controlling the amount of lectin clustering using mannose/hydroxyl-functionalized dendrimers. , 2003, Journal of the American Chemical Society.

[36]  R. Boucher,et al.  Release of cellular UDP-glucose as a potential extracellular signaling molecule. , 2003, Molecular pharmacology.

[37]  G. Burnstock,et al.  Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. , 2003, Trends in pharmacological sciences.

[38]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[39]  Mark W Grinstaff,et al.  Biodendrimers: new polymeric biomaterials for tissue engineering. , 2002, Chemistry.

[40]  Brian D. Athey,et al.  Structural Molecular Dynamics Studies on Polyamidoamine Dendrimers for a Therapeutic Application: Effects of pH and Generation , 2002 .

[41]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[42]  M. Cloninger,et al.  The lectin-binding properties of six generations of mannose-functionalized dendrimers. , 2002, Organic letters.

[43]  R. Haugland.  Handbook of fluorescent probes and research products , 2002 .

[44]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[45]  J. Chambers,et al.  A G Protein-coupled Receptor for UDP-glucose* , 2000, The Journal of Biological Chemistry.

[46]  D. Millar,et al.  Physicochemical characterization of generation 5 polyamidoamine dendrimers. , 2000, Biopolymers.

[47]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[48]  D. Pagé,et al.  Synthesis and biological properties of mannosylated starburst poly(amidoamine) dendrimers. , 1997, Bioconjugate chemistry.

[49]  Steven C. Zimmerman,et al.  Dendrimers in Supramolecular Chemistry: From Molecular Recognition to Self-Assembly. , 1997, Chemical reviews.

[50]  J. F. Stoddart,et al.  Synthetic carbohydrate-containing dendrimers , 1997 .

[51]  T. Lindhorst,et al.  Glycodendrimer synthesis without using protecting groups , 1997 .

[52]  T. K. Harden,et al.  Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s). , 1982, Molecular pharmacology.